GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » E10

PT Indofarma Tbk (ISX:INAF) E10 : Rp-26.58 (As of Sep. 2023)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PT Indofarma Tbk's adjusted earnings per share data for the three months ended in Sep. 2023 was Rp-23.023. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is Rp-26.58 for the trailing ten years ended in Sep. 2023.

During the past 3 years, the average E10 Growth Rate was 28.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PT Indofarma Tbk was 28.80% per year. The lowest was 28.80% per year. And the median was 28.80% per year.

As of today (2024-06-12), PT Indofarma Tbk's current stock price is Rp153.00. PT Indofarma Tbk's E10 for the quarter that ended in Sep. 2023 was Rp-26.58. PT Indofarma Tbk's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of PT Indofarma Tbk was 17878.79. The lowest was 0.00. And the median was 550.96.


PT Indofarma Tbk E10 Historical Data

The historical data trend for PT Indofarma Tbk's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk E10 Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -53.32 -3.55 -2.71 -19.23

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.36 -19.23 -22.52 -24.04 -26.58

Competitive Comparison of PT Indofarma Tbk's E10

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Indofarma Tbk's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's Shiller PE Ratio falls into.



PT Indofarma Tbk E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Indofarma Tbk's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-23.023/128.1514*128.1514
=-23.023

Current CPI (Sep. 2023) = 128.1514.

PT Indofarma Tbk Quarterly Data

per share eps CPI Adj_EPS
201309 -16.736 90.474 -23.706
201312 2.241 91.196 3.149
201403 -12.390 92.483 -17.168
201406 -4.039 93.015 -5.565
201409 4.914 94.576 6.659
201412 11.975 98.819 15.529
201503 -6.440 98.388 -8.388
201506 -1.246 99.766 -1.601
201509 -2.640 101.037 -3.348
201512 12.435 102.133 15.603
201603 -6.320 102.764 -7.881
201606 -2.675 103.212 -3.321
201609 -0.820 104.142 -1.009
201612 4.208 105.222 5.125
201703 -11.240 106.476 -13.528
201709 0.000 108.020 0.000
201712 5.764 109.017 6.776
201803 -2.740 110.097 -3.189
201806 2.820 111.085 3.253
201809 -11.405 111.135 -13.151
201812 0.760 112.430 0.866
201903 -7.030 112.829 -7.985
201906 -0.834 114.730 -0.932
201909 -3.383 114.905 -3.773
201912 13.810 115.486 15.325
202003 -6.910 116.252 -7.617
202006 5.410 116.630 5.944
202009 -4.590 116.397 -5.054
202012 6.100 117.318 6.663
202103 0.590 117.840 0.642
202106 -0.272 118.184 -0.295
202109 0.590 118.262 0.639
202112 -13.037 119.516 -13.979
202203 -16.510 120.948 -17.493
202206 -12.760 123.322 -13.260
202209 -29.812 125.298 -30.491
202212 -79.170 126.098 -80.459
202303 -19.940 126.953 -20.128
202306 -18.891 127.663 -18.963
202309 -23.023 128.151 -23.023

Add all the adjusted EPS together and divide 10 will get our e10.


PT Indofarma Tbk  (ISX:INAF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of PT Indofarma Tbk was 17878.79. The lowest was 0.00. And the median was 550.96.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PT Indofarma Tbk E10 Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Indofarma Tbk (ISX:INAF) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines